ARDSLEY ADVISORY PARTNERS LP Q3 2019 Filing

Filed November 14, 2019

Portfolio Value

$445.9M

Holdings

121

Report Date

Q3 2019

Filing Type

13F-HR

All Holdings (121 positions)

#StockSharesValue% PortfolioType
101
RVLVREVOLVE GROUP INC
13,000$304K0.07%
102
ZUOUSDZUORA INC
20,000$301K0.07%
103
TUSKMAMMOTH ENERGY SVCS INC
100,000$248K0.06%
104
ALDXALDEYRA THERAPEUTICS INC
47,100$248K0.06%
105
ALXNALEXION PHARMACEUTICALS INC
2,500$245K0.05%
106
HEXO CORP
60,000$238K0.05%
107
SIENUSDSIENTRA INC
30,000$194K0.04%
108
APOLLO ENDOSURGERY INC
50,188$165K0.04%
109
HROWHARROW HEALTH INC
25,000$141K0.03%
110
CSTMCONSTELLIUM SE
10,000$127K0.03%
111
GREENLANE HLDGS INC
35,000$119K0.03%
112
HC2 HLDGS INC
50,000$118K0.03%
113
SPARK ENERGY INC
10,000$106K0.02%
114
CBAYUSDCYMABAY THERAPEUTICS INC
20,000$102K0.02%
115
NEPTUNE WELLNESS SOLUTIONS I
25,000$89K0.02%
116
CAPSTONE TURBINE CORP
150,000$77K0.02%
117
ABEONA THERAPEUTICS INC
30,000$68K0.02%
118
SEELOS THERAPEUTICS INC
50,000$46K0.01%
119
NUVECTRA CORP
25,095$34K0.01%
120
CORREVIO PHARMA CORP
12,500$25K0.01%
121
ACTINIUM PHARMACEUTICALS INC
75,000$17K0.00%
PreviousPage 2 of 2